Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy
- PMID: 2414406
- DOI: 10.1016/0022-510x(85)90173-x
Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy
Abstract
We treated 17 patients with chronic inflammatory polyneuropathy (CIP) with infusions of fresh-frozen plasma (FFP). Thirteen patients had a beneficial response: 12 improved considerably and one moderately. The first signs of improvement were seen within 8 days of the onset of treatment. None of these patients had had spontaneous remissions for 2 months prior to treatment, and none had received immunosuppressive medication during the plasma infusions. The treatment effect was short-lasting in 9 patients. Re-institution of the FFP infusions was always followed by improvement. The same effect could be achieved by intravenous gamma-globulin. We conclude that infusions with FFP, of which the IgG fraction is the effective part, may induce a rapid and clinically important improvement in patients with CIP.
Similar articles
-
[Treatment of chronic immune-mediated polyneuropathies. State of the art and perspectives].Ann Med Interne (Paris). 2000 May;151 Suppl 1:1S19-23. Ann Med Interne (Paris). 2000. PMID: 10896984 Review. French.
-
Intravenous immunoglobulin therapy in the inflammatory neuropathies.Clin Exp Neurol. 1991;28:168-79. Clin Exp Neurol. 1991. PMID: 1821824 Review.
-
Intravenous gamma-globulin for chronic inflammatory demyelinating polyneuropathy and myasthenia gravis.West J Med. 1991 Jul;155(1):69. West J Med. 1991. PMID: 1715107 Free PMC article. No abstract available.
-
Prominent effect of immunoadsorption plasmapheresis therapy in a patient with chronic inflammatory demyelinating polyneuropathy associated with hepatitis B infection.Ther Apher. 1998 Nov;2(4):305-7. doi: 10.1111/j.1744-9987.1998.tb00128.x. Ther Apher. 1998. PMID: 10227761
-
Plasma exchange in chronic inflammatory polyneuropathy: evidence suggestive of a pathogenic humoral factor.Muscle Nerve. 1982 Jul-Aug;5(6):479-84. doi: 10.1002/mus.880050610. Muscle Nerve. 1982. PMID: 6752705
Cited by
-
Basic principles of intravenous immunoglobulin (IVIg) treatment.J Neurol. 2006 Sep;253 Suppl 5:V18-24. doi: 10.1007/s00415-006-5003-1. J Neurol. 2006. PMID: 16998749 Review.
-
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.Cochrane Database Syst Rev. 2024 Feb 14;2(2):CD001797. doi: 10.1002/14651858.CD001797.pub4. Cochrane Database Syst Rev. 2024. PMID: 38353301 Free PMC article.
-
Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments.J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):43-5. doi: 10.1136/jnnp.57.suppl.43. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964852 Free PMC article.
-
Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies.Curr Neuropharmacol. 2009 Dec;7(4):337-42. doi: 10.2174/157015909790031166. Curr Neuropharmacol. 2009. PMID: 20514213 Free PMC article.
-
In vitro effects of polyvalent immunoglobulin for intravenous use.J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):15-7. doi: 10.1136/jnnp.57.suppl.15. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964843 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical